Illumina Inc. stock gains on S&P 500 return and momentum upgrades
Published on 09/14/2026 at 11:04 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Illumina Inc. stock (ISIN US4523271090) is trading close to its consensus target after a strong run of about 57 percent from its 2025 closing level, supported by improving profitability and fresh index inclusion catalysts as of September 13, 2026.
Index return and recent performance
According to Tikr on September 13, 2026, Illumina has advanced roughly 57 percent from its 2025 close and is set to return to the S&P 500, with the mean analyst price target at about USD 202.65, essentially in line with the current trading level.
A comparative overview from Pluang on September 13, 2026 notes Illumina at USD 206.45 on Nasdaq, up 2.57 percent on the day, close to a consensus price target of USD 208.14, illustrating how the stock now trades near perceived fair value while still offering limited upside in the current analyst view.
Profitability recovery and fundamentals
The same Pluang analysis highlights that Illumina achieved positive net income of USD 850 million in fiscal 2025 after a period of losses, marking a clear turnaround in profitability that underpins the recent share price strength.
In addition, the article describes that Illumina shares have delivered consistent earnings beats, with an average surprise in recent quarters, supporting confidence that operational improvements are feeding through to the bottom line even as valuation multiples such as a price-earnings ratio of 38.52 remain demanding for growth-oriented investors.
Analyst sentiment and earnings momentum
Momentum-focused investors are paying attention to Illumina Inc. stock as analyst estimates move higher. According to Zacks on September 14, 2026, seven analysts have raised their fiscal 2026 earnings forecasts over the past 60 days, pushing the consensus earnings estimate up by USD 0.17 to USD 5.36 per share.
The same Zacks report notes that Illumina delivers an average earnings surprise of 9.7 percent and carries a Momentum Style Score of B, indicating that, while Zacks assigns only a rank of #3 (Hold), the stock shows favorable near-term trends in estimate revisions and price behavior for investors looking at momentum characteristics.
Valuation, technical picture and risks
The valuation and technical backdrop is more mixed. The Pluang comparison describes Illumina as trading on a price-earnings multiple of 38.52, with technical indicators currently bearish overall and the share price hovering near a pivot point resistance level around USD 203, suggesting limited room for short-term gains without fresh positive catalysts.
The same overview highlights that Illumina’s upcoming S&P 500 inclusion, effective September 21, 2026, could bolster institutional demand and liquidity, while at the same time execution on margin expansion and rising competition in the genomics and sequencing markets remain key risk factors that investors will have to monitor closely.
Stock price and market data
Illumina Inc. stock is referenced at USD 206.45 on Nasdaq in the Pluang snapshot dated September 13, 2026, showing a 2.57 percent gain on that trading day and positioning the shares only modestly below the consensus target of USD 208.14.
Illumina Inc. stock facts
- Company: Illumina Inc.
- ISIN: US4523271090
- Ticker: ILMN
- Trading venue: Nasdaq
- Price (as of September 13, 2026): 206.45 USD
- Sector / Industry: Health Care / Life Sciences Tools and Services
- Index membership: S&P 500 (effective September 21, 2026)
